Genmab — Oktober 2020
-
Ja, men ADC betaler alle udgifter
-
preclinical models, Mim8 shows 15-fold increased potency as compared to the marketed bispecific antibody emicizumab (Hemlibra
). -
Jan of course already told us that
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind